join our newsletter
Close Window
join our newsletter
Click here to print. << Back to All Newsletters
Study finds cannabis effective for 82% of migraine patients
Pain News Network
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
A survey of nearly 10,000 U.S. and Canadian migraine patients found that a third have tried medical cannabis to relieve their pain, and that 82% of those who have tried cannabis found it effective in providing pain relief.
Medical cannabis isn’t associated with cognitive problems for older adults, study finds
Forbes
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
A new study suggests medical cannabis use is not associated with cognitive problems in older adults. The results of the study conducted by researchers in Israel showed no statistically relevant differences between non-cannabis and cannabis users when it came to cognitive function.
Study: cannabis use increases for older Americans
Green Flower Media
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
A University of San Diego School of Medicine study shows that the stigma around cannabis continues to dissipate, especially in older Americans. They found that of the 600 patients surveyed (all over the age of 60), 15% of patients reported that they used the plant regularly for medical purposes, of which 61% of patients had only started using cannabis after age 60.
The race for artificial cannabinoids heats up
Bloomberg News Network
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
As of today, the cheapest way of generating the main active ingredient in cannabis, Delta-9-THC, is through traditional cultivation and extraction. However, some scientists anticipate that cannabinoids will be produced cost effectively in laboratories someday soon. “Soon” is the operative word, however, as the timeline for these moonshot projects is uncertain. The company that does solve the artificial cannabinoid puzzle will be positioned to reap vast rewards.
Delta-8-THC promises to get you high without the paranoia or anxiety
Discover Magazine
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
Delta-9-THC, the main active ingredient in cannabis plants, is a potent medicine capable of treating nausea, pain, and insomnia effectively. However, too much Delta-9-THC can trigger side effects such as paranoia, anxiety, and dizziness. Now some cannabis consumers are turning to an obscure analogue called Delta-8-THC. The difference between Delta-8 and Delta-9 is subtle. Both have medicinal benefits and are naturally occurring in the cannabis plant, but Delta-8 is about half as potent as Delta-9. Also, Delta-8 is federally legal under the 2018 Farm Bill.
<< Back to All Newsletters

The Power of Authenticity

"Your brand is what other people say about you when you're not in the room." —Jeff Bezos‍. Brand building is difficult and truly is “an art, not a science.” What consumers really want is not always clear, and that appears to be especially true when it comes to cannabis. With legalization, hundreds of cannabis brands have popped up for the “cannasseur” and “canna-curious” alike. While it is always difficult to determine exactly what makes a brand successful, we have found that the industry’s strongest brands share one common trait - authenticity. Brands that tell a story - be it through a founder’s history, pioneering products, or a real embrace of cannabis culture - can drive a lifelong relationship with a consumer. This week, we highlight some companies that are demonstrating “the power of authenticity.”

CONTINUE READING